Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bouncing Metformin Intervention Study
NL-OMON51497Terminated
- Sponsor
- Bethesda Diabetes Research Center
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Bethesda Diabetes Research Center. Primary endpoints: Diabetes remission and Reduction of HbA1c. Started Jun 2023; status: terminated.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON51497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51497.